<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11" class="ref">
 <label class="label">11</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Shen</surname>
    <given-names class="given-names">K.-H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lin</surname>
    <given-names class="given-names">E.-S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kuo</surname>
    <given-names class="given-names">P.-L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Chen</surname>
    <given-names class="given-names">C.-Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hsu</surname>
    <given-names class="given-names">Y.-L.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Isolinderanolide B, a butanolide extracted from the stems of Cinnamomum subavenium, inhibits proliferation of T24 human bladder cancer cells by blocking cell cycle progression and inducing apoptosis</article-title>
  <source class="source">
   <italic toggle="yes" class="italic">Integrative Cancer Therapies</italic>
  </source>
  <year class="year">2011</year>
  <volume class="volume">10</volume>
  <issue class="issue">4</issue>
  <fpage class="fpage">350</fpage>
  <lpage class="lpage">358</lpage>
  <pub-id pub-id-type="other" class="pub-id">2-s2.0-80052029852</pub-id>
  <pub-id pub-id-type="doi" class="pub-id">10.1177/1534735410391662</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">21196431</pub-id>
 </element-citation>
</ref>
